Reply to "Nonstop treatment of cystic fibrosis"

1. Howard, M., Frizzell, R.A. & Bedwell, D.M. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nature Med. 2, 467−469 (1996). | Article | PubMed  | ISI | ChemPort |
2. Maquat, L.E. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1, 453−465 (1995). | PubMed  | ISI | ChemPort |
3. Dietz, H.C. et al. The skipping of constitutive exons in vivo induced by nonsense mutations. Science 259, 680−683 (1993). | PubMed  | ISI | ChemPort |
4. Dietz, H.C. & Kendzior, R.J., Jr. Maintenance of an open reading frame as an additional level of scrutiny during splice site selection. Nature Genet. 8, 183−188 (1994). | PubMed  | ISI | ChemPort |
5. Hamosh, A. et al. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J. Clin. Invest. 88, 1880−1885 (1991). | PubMed  | ISI | ChemPort |
6. Hamosh, A., Rosenstein, B.J. & Cutting, G.R. CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in nasal epithelial cells. Hum. Mol. Genet. 1, 542−544 (1992). | PubMed  | ChemPort |
7. Hull, J.S. et al. The stop mutation R553X in the CFTR gene results in exon skipping. Genomics 19, 362−364 (1994). | Article | PubMed  | ISI | ChemPort |
8. Dorin, J.R. et al. Phenotypic consequence of CFTR modulation in mutant mice: Implications for somatic gene therapy. Pediatr. Pulmonol. 12 (suppl.), 231 (1995).
9. Belgrader, P., Cheng, J. & Maquat, L.E. Evidence to implicate translation by ribosomes in the mechanism by which nonsense codons reduce the nuclear level of human triosephosphate isomerase mRNA. Proc. Natl. Acad. Sci. USA 90, 482−486 (1993). | PubMed  | ChemPort |
10. Naeger, L.K., Schoberg, R.V., Zhao, Q., Tullis, G.E. & Pintel, D.J. Nonsense mutations inhibit splicing of MVM RNA in cis when they interrupt the reading frame of either exon of the final spliced product. Genes Dev. 6, 1107−1119 (1992). | PubMed  | ISI | ChemPort |
11. Qian, L. et al. T cell receptor- mRNA splicing: Regulation of unusual splicing intermediates. Mol. Cell. Biol. 13, 1686−1696 (1993). | PubMed  | ISI | ChemPort |
12. Menon, K.P. & Neufeld, E.F. Evidence for degradation of mRNA encoding alpha-L-iduronidase in Hurler fibroblasts with premature termination alleles. Cell Mol. Biol. 40, 999−1005 (1994). | ISI | ChemPort |
13. Chang, J.C. & Kan, Y.W. ⁰ thalassemia, a nonsense mutation in man. Proc. Natl. Acad. Sci. USA 76, 2886−2889 (1979). | PubMed  | ChemPort |

	Top

	Top